SCHEDULE OF ISSUANCE OF WARRANTS TO PURCHASE COMMON STOCK (Details)	3 Months Ended
	Mar. 31, 2026 $ / shares shares
IssuanceOfWarrantsLineItems [Line Items]
Number of underlying common stock	25,828,164
Series J Warrants [Member]
IssuanceOfWarrantsLineItems [Line Items]
Number of underlying common stock	12,914,086
Weighted average exercise price | $ / shares	$ 1.3827
Expiration date	*	[1]
Series K Warrants [Member]
IssuanceOfWarrantsLineItems [Line Items]
Number of underlying common stock	12,914,078
Weighted average exercise price | $ / shares	$ 1.3827
Expiration date	*	[1]

[1] The Series J Warrants and Series K Warrants have a term of the earlier of (i) May 15, 2028 and (ii) (A) in the case of the Series J Warrants, 20 trading days following the Company’s announcement of receipt of FDA approval for the SwitchGuard and CGuard Prime 80 cm and (B) in the case on the Series K Warrants, 20 trading days following the end of the fourth fiscal quarter after the fiscal quarter in which the first commercial sales of CGuard Prime in the U.S. begins. Following the commencement of the first commercial sales of CGuard Prime in the United States, which occurred during the third fiscal quarter of 2025 in July 2025, the Series K Warrants are scheduled to expire twenty (20) trading days after the end of the fourth fiscal quarter thereafter, which is October 28, 2026.